https://economictimes.indiatimes.com/markets/stocks/news/mope-and-invascent-buy-70-in-symbiotec-for-100-m/articleshow/67140276.cms
Symbiotec: MOPE and InvAscent buy 70% in Symbiotec for $100 m - The Economic Times
PE fund Actis sells the stake in API maker, valuing company at $140 m.
https://symbiotec.com/
Symbiotec - Driving Innovation in Biotech APIs
driving innovationsymbiotecbiotechapis
https://economictimes.indiatimes.com/markets/ipos/fpos/sael-industries-vishvaraj-environment-symbiotec-pharmalab-and-3-others-get-sebi-nod-to-launch-ipo/articleshow/129850018.cms?from=mdr
SAEL Industries, Vishvaraj Environment, Symbiotec Pharmalab and 3 others get Sebi nod to launch IPO...
Securities and Exchange Board of India approved IPOs of six companies, including Vishvaraj Environment and SAEL Industries. Firms span sectors like renewable...
https://ventureintelligence.blogspot.com/2011/09/deal-alert-franklin-templeton-pe.html
Deal Alert: Franklin Templeton PE invests Rs.45-Cr in Symbiotec Pharma
Edited excerpts from the Press Release: Franklin Templeton Private Equity Strategy, a private equity portfolio advised by Darby Asia Investo...
deal alertfranklin templeton